Trade Catalent Inc - CTLT CFD

Trading Conditions

• Spread: 0.16
• Long position overnight feeLong position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position-0.026179 %(-$1.05)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position0.003957 %($0.16)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-$1.05)

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  ($0.16)

Key Stats

• Prev. Close: 55.59
• Open: 55.6
• 1-Year Change: 69.46%
• Day's Range: 55.29 - 55.94

Catalent Company profile

Catalent Pharma is the US number one health products and solutions provider. The company specialises in biologics, pre-formulation and formulation and runs its own optoform technology. Catalent Pharma prides itself on 1,300 patents and 7,000 products currently in market. The company's operations stretch across Asia Pacific, Europe, Latin America, and North America, covering more than 100 global markets.

 

Since 2014, Catalent stocks have been traded on the New York Stock Exchange (NYSE) under the CTLT ticker. The company is featured in the Top 50 pharma and Top 50 biotech companies lists. As of May 2018, the Catalent market cap reached 5.348B.

 

Browse the latest Catalent share price data and tap into the pharma industry at Capital.com.